Krystal Biotech Free Cash Flow Analysis

Krystal Biotech, Inc. (KRYS)

246.61 +6.89 (+2.87%) USD | NASDAQ | Dec 11, 16:00

246.61 0.00 (0.00%) After-Hours: 20:00

View Free Cash Flow for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Free Cash Flow Chart

Start Trial

View Historical Data

Start Trial

View Free Cash Flow Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Free Cash Flow Benchmarks

Start Trial

Alnylam Pharmaceuticals, Inc.	221.36M
Vanda Pharmaceuticals, Inc.	-82.95M
ADMA Biologics, Inc.	40.61M
Aldeyra Therapeutics, Inc.	-40.08M
ACADIA Pharmaceuticals, Inc.	98.97M

Cash from Operations (Quarterly)	39.66M
Cash from Investing (Quarterly)	-4.286M
Cash from Financing (Quarterly)	3.709M
Free Cash Flow Per Share (Quarterly)	1.272
Free Cash Flow to Equity (Quarterly)	38.12M
Free Cash Flow to Firm (Quarterly)	37.96M
Free Cash Flow Yield	2.25%